ADVR Granted Therapeutic Composition Patent For Product R
U.S. Patent Awarded for Chemical Structure of Novel Peptide Nucleic Acid
27-Mar-2003 -
Advanced Viral Research
Corp. announced that it has been awarded an U.S.
Patent, entitled "Preparation of a Therapeutic Composition,"
for Product R, the peptide nucleic acid immunomodulator currently in clinical
trials in Israel.
The claims of the newly issued patent focus on the chemical ...
acids
anemia
basal cell carcinoma
+10